ADHD in adults: Does age at diagnosis matter?

C Hutt Vater, M DiSalvo, A Ehrlich… - Journal of attention …, 2024 - journals.sagepub.com
Objective: To provide additional information about clinical features associated with adult
ADHD in patients diagnosed in childhood compared to those first diagnosed in adulthood …

Pharmacological neuroenhancement: current aspects of categorization, epidemiology, pharmacology, drug development, ethics, and future perspectives

J Daubner, MI Arshaad, C Henseler… - Neural …, 2021 - Wiley Online Library
Recent pharmacoepidemiologic studies suggest that pharmacological neuroenhancement
(pNE) and mood enhancement are globally expanding phenomena with distinctly different …

Potential risk groups and psychological, psychosocial, and health behavioral predictors of pharmacological neuroenhancement among university students in Germany

S Heller, AN Tibubos, TA Hoff, AM Werner… - Scientific reports, 2022 - nature.com
Aiming to develop and implement intervention strategies targeting pharmacological
neuroenhancement (PN) among university students more specifically, we (1) assessed the …

Pediatric attention deficit hyperactivity disorder (ADHD): 2022 updates on pharmacological management

L O'Connor, S Carbone, A Gobbo… - Expert Review of …, 2023 - Taylor & Francis
Introduction Pediatric attention-deficit disorder (ADHD) impacts a significant percentage of
the population world-wide. Pharmacologic treatments have been shown to be safe and …

Sensitization-based risk for substance abuse in vulnerable individuals with ADHD: Review and re-examination of evidence

I Ivanov, JM Bjork, J Blair, JH Newcorn - Neuroscience & Biobehavioral …, 2022 - Elsevier
Evidence of sensitization following stimulants administration in humans is just emerging,
which prevents reaching more definitive conclusions in favor or against a purported …

[图书][B] Children in difficulty: A guide to understanding and helping

J Elliott, M Place - 2012 - taylorfrancis.com
Written by two leading experts in the field, this welcome third edition of Children in Difficulty:
A guide to understanding and helping discusses some of the most common, yet …

Evidence of methylphenidate effect on mitochondria, redox homeostasis, and inflammatory aspects: Insights from animal studies

LN Foschiera, F Schmitz, ATS Wyse - Progress in Neuro …, 2022 - Elsevier
Methylphenidate (MPH) is a central nervous system (CNS) stimulant known for its
effectiveness in the treatment of Attention Deficit Hyperactivity Disorder (ADHD), a …

Signals of increasing co-use of stimulants and opioids from online drug forum data

A Sarker, MA Al-Garadi, Y Ge, N Nataraj… - Harm Reduction …, 2022 - Springer
Background Despite recent rises in fatal overdoses involving multiple substances, there is a
paucity of knowledge about stimulant co-use patterns among people who use opioids …

Assessing undertreatment and overtreatment/misuse of ADHD medications in children and adolescents across continents: A systematic review and meta-analysis

R Massuti, CR Moreira-Maia, F Campani… - Neuroscience & …, 2021 - Elsevier
A controversy exists on whether there is an over or underuse of medications for Attention-
Deficit/Hyperactivity Disorder (ADHD). We conducted the first meta-analysis to estimate the …

Effects of l-theanine–caffeine combination on sustained attention and inhibitory control among children with ADHD: a proof-of-concept neuroimaging RCT

CN Kahathuduwa, S Wakefield, BD West, J Blume… - Scientific reports, 2020 - nature.com
We examined the acute effects of l-theanine, caffeine and their combination on sustained
attention, inhibitory control and overall cognition in boys with attention deficit hyperactivity …